Stocks to sell

I recommended Moderna (NASDAQ:MRNA) stock in late 2020 as part of a decade-long trend.  But MRNA stock has been taken over by events surrounding the company’s COVID-19 vaccine. Source: Shutterstock Through the first three quarters of 2021, Moderna racked up $11.26 billion in sales. Analysts expect another $5.9 billion to come rolling in for Q4.

In recent weeks, QuantumScape (NYSE:QS) has made significant progress, improving the company’s outlook. Still, the valuation of QS stock remains very high, and the company continues to face major risks. Source: Michael Vi / Shutterstock.com Among these risks, as Morgan Stanley recently pointed out, are tough competition and the possibility that the production of electric

While AMC Entertainment (NYSE:AMC) stock has been trending lower over the last few weeks,  it remains a meme stock king. Despite many warning signs that it’s set to experience a dramatic price drop, AMC stock is still up 1,500% in 2021. The huge gains have been mostly caused by the so-called “ape army” that makes

As you may recall, shares in online textbook and tutoring company Chegg (NYSE:CHGG) cratered in price last month. After reporting underwhelming quarterly results and guidance on Nov. 1, CHGG stock dropped 48.8% the following trading day alone. It tanked from just under $60 per share, to around $32 per share. Source: Casimiro PT / Shutterstock.com In

Deciphera Pharmaceuticals (NASDAQ:DCPH) is a biotech company that develops drugs mainly for the treatment of cancer. Right now, DCPH stock shares are down nearly 85% year-to-date (YTD), at $7.70 as of the close of Nov. 29. Source: Iryna Imago / Shutterstock.com Of course, with Thanksgiving just over, it’s probably appropriate to note that I’m thankful for

When you chase after a stock that has gone too far without justification, you’re likely to get punished. That’s a lesson learned by many of Jumia Technologies’ (NYSE:JMIA) shareholders, as JMIA stock has been taking a beating lately. Source: farzand01 / Shutterstock.com As the old saying goes, the trend is your friend. There’s nothing friendly about

Like many other pandemic winners, Zoom Video Communications (NASDAQ:ZM) stock is a pandemic darling that made the most of the moment. Source: Michael Vi / Shutterstock.com The growth story of Zoom is like no other as it became a household name in no time. It may not be correct to say that the pandemic is

As a long-term, buy-and-hold investment, Didi (NYSE:DIDI) stock is a highly logical choice. That said, there’s just too much regulatory risk.  Source: Piotr Swat / Shutterstock.com There seems to be mounting evidence that the ridesharing company faces a potential delisting from the New York Stock Exchange. It is well known that China continues a broad

The S&P 500 is on fire at the moment on the heels of an excellent earnings season. It seems that nothing can stop the current bull run as the markets have proved very resilient. But some are still sounding the alarm that a steep market correction is near, which means it is the right time

SoFi Technologies (NASDAQ:SOFI) is a fintech company seeking to disrupt the traditional banking market. SOFI stock officially launched earlier this year after it completed a merger with one of Chamath Palihapitiya’s special purpose acquisition companies (SPACs). Source: rafapress / Shutterstock.com Out of the gate, SoFi generated a lot of excitement. Unlike some of its fintech

When investors abandoned Peloton (NASDAQ:PTON) stock in droves after the company posted quarterly results on Nov. 4, people should have expected it. Source: JHVEPhoto / Shutterstock.com Since July, when PTON stock peaked, bulls failed to take the share price above the 50 and 200 day moving averages. The leisure stationary exercise bike maker suffers from

For the last few months I have been warning investors away from Vinco Ventures (NASDAQ:BBIG) stock. Since my first story came out in September, the shares are down 67%. They closed November 23 at $3.13. Source: shutterstock.com/Postmodern Studio My problem with the company is that there is nothing there. It’s all hype and buzzwords like streaming

As I expected, traders have kept selling Ocugen (NASDAQ:OCGN) stock in the wake of the recent news about the company. The biotech firm — which is trying to bring  Covaxin, a Covid-19 vaccine, to the U.S. and Canada — surged a few weeks back. Last month,  traders bid up OCGN stock in anticipation of an

GameStop (NYSE:GME) stock still trades at above its pre-squeeze levels, which is astounding. Source: Shutterstock / mundissima GME stock boasts a year-to-date price return of over 1,035%. Although it is trading considerably below its all-time highs of $483, it still trades at elevated levels. You can buy it today for a little more than $210,

NerdWallet (NASDAQ:NRDS) completed its IPO on Nov. 8 at $18.00 per share and subsequently, the stock shot up. The company was able to raise $135 million in equity capital, including the brokers’ greenshoe option. As a result, at $27.22 at the close on Nov. 22, NRDS stock now has a $1.8 billion market capitalization. In

Although Gevo (NASDAQ:GEVO) made a few positive deals recently and it could benefit from multiple government initiatives, the company is still facing difficult hurdles. Moreover, the valuation of GEVO stock remains elevated, given the company’s uncertain outlook. Source: Scharfsinn / Shutterstock.com As a result of the company’s challenges and weaknesses, along with its high valuation,

Buying stocks on dips can sometimes be a profitable strategy. However, grabbing shares of Paysafe (NYSE:PSFE) could be harmful to your fiscal health, as PSFE stock has entered into a harsh and persistent bear market. Source: Sulastri Sulastri / Shutterstock.com If you abide by the principle of “the trend is your friend,” then there’s nothing

With Thanksgiving and other winter holidays fast approaching, it’s a good practice to stop and consider what we’re grateful for. When it comes to the professional realm, I’m appreciative for the ability to get paid for crafting (hopefully) compelling stories. Through this journey, I’ve reached out to millions and even make regular TV appearances. But

There is little leg room remaining in Lucid (NASDAQ:LCID) stock. Shares of the electric vehicle (EV) manufacturer have been up 86.4% in the last month. That makes it firmly overvalued.  Source: Around the World Photos / Shutterstock.com The electric car has been the go-to for people looking to make their carbon footprint smaller. EV technology

Exela Technologies (NASDAQ:XELA) reported lackluster third-quarter results earlier this month. The business process automation firm saw a steep decline in revenue growth and missed analyst expectations on both lines by a fair margin. To make matters worse, is it has a burgeoning debt load. All together, this makes XELA stock a remarkably risky investment. Source: